Long-term mortality in HIV patients virally suppressed for more than three years with incomplete CD4 recovery: A cohort study

<p>Abstract</p> <p>Background</p> <p>The mortality in patients with persistent low CD4 count despite several years of HAART with sustained viral suppression is poorly documented. We aimed to identify predictors for inadequate CD4 cell recovery and estimate mortality in...

Full description

Bibliographic Details
Main Authors: Jensen Janne, Røge Birgit, Pedersen Gitte, Larsen Carsten S, Kronborg Gitte, Gerstoft Jan, Engsig Frederik N, Nielsen Lars N, Obel Niels
Format: Article
Language:English
Published: BMC 2010-11-01
Series:BMC Infectious Diseases
Online Access:http://www.biomedcentral.com/1471-2334/10/318
_version_ 1811317169312497664
author Jensen Janne
Røge Birgit
Pedersen Gitte
Larsen Carsten S
Kronborg Gitte
Gerstoft Jan
Engsig Frederik N
Nielsen Lars N
Obel Niels
author_facet Jensen Janne
Røge Birgit
Pedersen Gitte
Larsen Carsten S
Kronborg Gitte
Gerstoft Jan
Engsig Frederik N
Nielsen Lars N
Obel Niels
author_sort Jensen Janne
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>The mortality in patients with persistent low CD4 count despite several years of HAART with sustained viral suppression is poorly documented. We aimed to identify predictors for inadequate CD4 cell recovery and estimate mortality in patients with low CD4 count but otherwise successful HAART.</p> <p>Method</p> <p>In a nationwide cohort of HIV patients we identified all individuals who started HAART before 1 January 2005 with CD4 cell count ≤ 200 cells/μL and experienced three years with sustained viral suppression. Patients were categorized according to CD4 cell count after the three years suppressed period (≤ 200 cells/μL; immunological non-responders (INRs), >200 cells/μL; immunological responders (IRs)). We used logistic regression and Kaplan-Meier analysis to estimated risk factors and mortality for INRs compared to IRs.</p> <p>Results</p> <p>We identified 55 INRs and 236 IRs. In adjusted analysis age > 40 years and > one year from first CD4 cell count ≤ 200 cells/μL to start of the virologically suppressed period were associated with increased risk of INR. INRs had substantially higher mortality compared to IRs. The excess mortality was mainly seen in the INR group with > one year of immunological suppression prior to viral suppression and injection drug users (IDUs).</p> <p>Conclusion</p> <p>Age and prolonged periods of immune deficiency prior to successful HAART are risk factors for incomplete CD4 cell recovery. INRs have substantially increased long-term mortality mainly associated with prolonged immunological suppression prior to viral suppression and IDU.</p>
first_indexed 2024-04-13T12:02:10Z
format Article
id doaj.art-f31fff828db942dc890a61263e0b99a0
institution Directory Open Access Journal
issn 1471-2334
language English
last_indexed 2024-04-13T12:02:10Z
publishDate 2010-11-01
publisher BMC
record_format Article
series BMC Infectious Diseases
spelling doaj.art-f31fff828db942dc890a61263e0b99a02022-12-22T02:47:45ZengBMCBMC Infectious Diseases1471-23342010-11-0110131810.1186/1471-2334-10-318Long-term mortality in HIV patients virally suppressed for more than three years with incomplete CD4 recovery: A cohort studyJensen JanneRøge BirgitPedersen GitteLarsen Carsten SKronborg GitteGerstoft JanEngsig Frederik NNielsen Lars NObel Niels<p>Abstract</p> <p>Background</p> <p>The mortality in patients with persistent low CD4 count despite several years of HAART with sustained viral suppression is poorly documented. We aimed to identify predictors for inadequate CD4 cell recovery and estimate mortality in patients with low CD4 count but otherwise successful HAART.</p> <p>Method</p> <p>In a nationwide cohort of HIV patients we identified all individuals who started HAART before 1 January 2005 with CD4 cell count ≤ 200 cells/μL and experienced three years with sustained viral suppression. Patients were categorized according to CD4 cell count after the three years suppressed period (≤ 200 cells/μL; immunological non-responders (INRs), >200 cells/μL; immunological responders (IRs)). We used logistic regression and Kaplan-Meier analysis to estimated risk factors and mortality for INRs compared to IRs.</p> <p>Results</p> <p>We identified 55 INRs and 236 IRs. In adjusted analysis age > 40 years and > one year from first CD4 cell count ≤ 200 cells/μL to start of the virologically suppressed period were associated with increased risk of INR. INRs had substantially higher mortality compared to IRs. The excess mortality was mainly seen in the INR group with > one year of immunological suppression prior to viral suppression and injection drug users (IDUs).</p> <p>Conclusion</p> <p>Age and prolonged periods of immune deficiency prior to successful HAART are risk factors for incomplete CD4 cell recovery. INRs have substantially increased long-term mortality mainly associated with prolonged immunological suppression prior to viral suppression and IDU.</p>http://www.biomedcentral.com/1471-2334/10/318
spellingShingle Jensen Janne
Røge Birgit
Pedersen Gitte
Larsen Carsten S
Kronborg Gitte
Gerstoft Jan
Engsig Frederik N
Nielsen Lars N
Obel Niels
Long-term mortality in HIV patients virally suppressed for more than three years with incomplete CD4 recovery: A cohort study
BMC Infectious Diseases
title Long-term mortality in HIV patients virally suppressed for more than three years with incomplete CD4 recovery: A cohort study
title_full Long-term mortality in HIV patients virally suppressed for more than three years with incomplete CD4 recovery: A cohort study
title_fullStr Long-term mortality in HIV patients virally suppressed for more than three years with incomplete CD4 recovery: A cohort study
title_full_unstemmed Long-term mortality in HIV patients virally suppressed for more than three years with incomplete CD4 recovery: A cohort study
title_short Long-term mortality in HIV patients virally suppressed for more than three years with incomplete CD4 recovery: A cohort study
title_sort long term mortality in hiv patients virally suppressed for more than three years with incomplete cd4 recovery a cohort study
url http://www.biomedcentral.com/1471-2334/10/318
work_keys_str_mv AT jensenjanne longtermmortalityinhivpatientsvirallysuppressedformorethanthreeyearswithincompletecd4recoveryacohortstudy
AT røgebirgit longtermmortalityinhivpatientsvirallysuppressedformorethanthreeyearswithincompletecd4recoveryacohortstudy
AT pedersengitte longtermmortalityinhivpatientsvirallysuppressedformorethanthreeyearswithincompletecd4recoveryacohortstudy
AT larsencarstens longtermmortalityinhivpatientsvirallysuppressedformorethanthreeyearswithincompletecd4recoveryacohortstudy
AT kronborggitte longtermmortalityinhivpatientsvirallysuppressedformorethanthreeyearswithincompletecd4recoveryacohortstudy
AT gerstoftjan longtermmortalityinhivpatientsvirallysuppressedformorethanthreeyearswithincompletecd4recoveryacohortstudy
AT engsigfrederikn longtermmortalityinhivpatientsvirallysuppressedformorethanthreeyearswithincompletecd4recoveryacohortstudy
AT nielsenlarsn longtermmortalityinhivpatientsvirallysuppressedformorethanthreeyearswithincompletecd4recoveryacohortstudy
AT obelniels longtermmortalityinhivpatientsvirallysuppressedformorethanthreeyearswithincompletecd4recoveryacohortstudy